Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 16/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LPL | P06858 | 2/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22300078 | 0.93 | MAPK14 (0.40) | MAPK14KDM4ELPLLIPG | |
| SCHEMBL22299971 | 0.85 | LIPG (0.47) | KDM4EMAPTLPLLIPG | |
| Ammonia Solution, Strong SCHEMBL28495870 | 0.84 | LIPG (0.46) | KDM4EMAPTLPLLIPG | |
| SCHEMBL22299905 | 0.81 | CYP2A6 (0.41) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL22299904 | 0.70 | KDM4E (0.38) | KDM4ECYP1A2MAPTLPLLIPG | |
| SCHEMBL24319012 | 0.69 | KDM4E (0.41) | MAPK14KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2009965 | 0.69 | CYP2A6 (0.47) | LPLLIPG | |
| SCHEMBL22299906 | 0.69 | MAPK14 (0.39) | MAPK14LPLLIPG | |
| SCHEMBL10019510 | 0.69 | — | — | |
| SCHEMBL15803153 | 0.68 | LIPG (0.49) | MAPTLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-31 | — | — | US | disclosed |
| WO-2020159249-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | AOX1, OXER1, OR51E2 | MAPK14 773/4885KDM4E 3241/4885CYP1A2 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.